Hypoglycemia associated with maprotiline in a patient with type 1 diabetes [10]

Diabetes Care

Volumn 22, Issue 5, 1999, Pages 862-863

  Isotani, Haruhiko ^a,b   Kameoka, Keiichi ^a  

^a Hirakata City Hospital   (Japan)

^b Hirakata City Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; MAPROTILINE;

ADULT; CASE REPORT; DEPRESSION; DIABETES CONTROL; DRUG HALF LIFE; FEMALE; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; LETTER; PARESTHESIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD GLUCOSE; C-PEPTIDE; DEPRESSIVE DISORDER; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCAGON; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MAPROTILINE;

EID: 0032945026     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.5.862     Document Type: Letter

References (6)

1. Zogno MG, Tolfo L, Drachi E: Hypoglycemia caused by maprotiline in a patient taking oral antidiabetics. Ann Pharmacother 28:406-407, 1994
2. Shirivastava RK, Edwards D: Hypoglycemia associated with imipramine. Biol Psychiatry 18:1509-1510, 1983
3. Kobayashi T, Itoh T, Kosaka K, Sato K, Tsuji K: Time course of islet cell antibodies and B-cell function in non-insulin-dependent stage of type 1 diabetes. Diabetes 36:510-517, 1987
4. Martindale W: The Extra Pharmacopoeia. 30th ed. London, Pharmacutical Press, 1993, p.263
5. Faber OK, Binder C: C-peptide response to glucagon: a test for the residual beta-cell function in diabetes mellitus. Diabetes 26:605-610, 1977
6. Castillo MJ, Scheen AJ, Lefebvre PJ: Modified glucagon test allowing simultaneous estimation of insulin secretion and insulin sensitivity: application to obesity, insulin-dependent diabetes mellitus, and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 80:393-399, 1995